Zimmer Biomet Holdings Inc. (ZBH)

116.56
0.14 0.12
NYSE : Health Technology
Prev Close 116.42
Open 115.86
Day Low/High 115.17 / 116.60
52 Wk Low/High 96.99 / 134.55
Volume 341.44K
Avg Volume 1.19M
Exchange NYSE
Shares Outstanding 204.80M
Market Cap 24.18B
EPS -1.90
P/E Ratio N/A
Div & Yield 0.96 (0.81%)

Latest News

Don't Get Out of Joint

Don't Get Out of Joint

Demand for artificial joints is growing, and Zimmer Biomet is a good way to play the demographic trend.

Cramer: We Have Nothing to Distinguish the Stocks Right Now

Cramer: We Have Nothing to Distinguish the Stocks Right Now

We know that we are in the era when index managers are ascendant.

These 4 Healthcare Charts Are Signaling Buys

These 4 Healthcare Charts Are Signaling Buys

Here's a rundown of four technical setups that are showing solid trading potential.

A Play on Intel's Breakdown

A Play on Intel's Breakdown

With trend favoring the bears, I'm favoring a bearish call spread.

Here's a New List of Stocks That Show Bullish or Bearish Reversal Patterns

Here's a New List of Stocks That Show Bullish or Bearish Reversal Patterns

These companies show signs of a change of direction.

Zimmer Biomet's 'Island' Pattern Is Interesting, but Is It Significant?

Zimmer Biomet's 'Island' Pattern Is Interesting, but Is It Significant?

If prices continue higher they are likely to encounter resistance above $120.

Zimmer Biomet Provides Upbeat Guidance

Zimmer Biomet Provides Upbeat Guidance

The medical device maker expects sales of $2 billion in the fourth quarter, topping Wall Street expectations of $1.97 billion.

3 Bargain-Priced Health-Care Stocks

3 Bargain-Priced Health-Care Stocks

Current valuations are at record lows, despite the companies having good prospects.

Jim Cramer Says Don't Trade Stocks Based on Trump Cabinet Nominations

Jim Cramer Says Don't Trade Stocks Based on Trump Cabinet Nominations

Investors shouldn't be buying certain healthcare stocks based on Donald Trump's nomination of Tom Price as HHS chief, says Jim Cramer.

Some Black Friday Stock Market Buys

ZBH's Big Unjustified Price Correction

ZBH's Big Unjustified Price Correction

Shares are trading at less than 12.5x 2017's EPS estimates and should rise soon.

Cramer: How Bad Was Today? Let Us Count the Ways

Cramer: How Bad Was Today? Let Us Count the Ways

Today there was a virtual vacuum of good news in the stock market.

Zimmer Biomet's Chart Needs Repair

Zimmer Biomet's Chart Needs Repair

ZBH needs to stop falling and eventually make a low.

Cramer: With the Election Coming, Valeant's Problem Is Increasing

Cramer: With the Election Coming, Valeant's Problem Is Increasing

We have to ask: where is the cash flow to pay off the debt, if any important prices are rolled back?

Zimmer Biomet Lowers Full-Year Forecasts

Zimmer Biomet Lowers Full-Year Forecasts

Shares of Zimmer Biomet were under pressure Monday after cutting its full-year forecast.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Here's a window into what institutional investors may be doing and how to profit from that.

Trending Tickers: CVX, NKE, ZBH, L

Trending Tickers: CVX, NKE, ZBH, L

Analyst action changes the outlook for the oil industry, while shareholders are running from Nike.

Cramer: Nike Is a Victim of Price Wars; There Will Be Others

Cramer: Nike Is a Victim of Price Wars; There Will Be Others

Look out below when it comes to margins, as the price wars extend to sneakers, drugs and others.

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

But several airline and retail stocks are proving highly volatile.

Anything These Guys Are Selling, I'm not Buying

Anything These Guys Are Selling, I'm not Buying

When KKR and Apollo sell a stock it should be a huge red flag to investors to consider following suit.

Private Equity Selloffs Likely to Ding More Stocks

Private Equity Selloffs Likely to Ding More Stocks

Names that shareholders should watch are those where PE firms hold big stakes in their companies.

4 Standout Medical Technology Stocks

4 Standout Medical Technology Stocks

Medical technology companies are hot and not even climbing price-to-earnings multiples will slow down the likes of Hologic, Zimmer Biomet, Zeltiq and NuVasive.

Zimmer Biomet and NuVasive Could be a Spine-Tingling Combination

Zimmer Biomet and NuVasive Could be a Spine-Tingling Combination

Zimmer Biomet is on track to return to growth, which could signal more mergers and acquisitions within the industry.

Cramer: These Stocks Are the Key to the Bull Market

Cramer: These Stocks Are the Key to the Bull Market

Let me give you the unassailable themes.

Jim Cramer: Zimmer-LDR Deal Is Great

Jim Cramer: Zimmer-LDR Deal Is Great

Zimmer Biomet's move to acquire LDR Holding is a smart one and it also bodes well for another medical device company NuVasive, said TheStreet's Jim Cramer.

Cramer: It's Amazing How Fickle the Market Can Be

This market has taken some frantic turns from one group to the other.

9 Health Names to Like Amid the Rhetoric

9 Health Names to Like Amid the Rhetoric

Candidates have decried rising drug and medical prices, but there are reasons to like these stocks.